Here are the highlights from the large-scale study: The test subjects included 1900 patients, all of whom had body-mass indexes of over 30, meaning they qualified as clinically obese Each participant received either 2.4 mg of semaglutide injected subcutaneously (under the skin) or a placebo The trial lasted over a year At the end of the trial, the patients who received semaglutide experienced a 14.9% loss in excess body weight
Ozempic and Wegovy (semaglutide) In 2020 The FDA approved Ozempic (semaglutide) for the reduction of stroke, heart attack, and other major adverse cardiovascular events (MACE) in adults with type 2 diabetes and heart disease
KPV, a naturally occurring tripeptide derived from -MSH, is being researched for its potent anti-inflammatory properties and ability to downregulate pro-inflammatory cytokines
According to Rossow, each year in the United States, approximately 20,000 people die from alcohol-attributable cancers, while new cancer cases related to alcohol are approximately 75,000
Enhances Circulation & Nerve Oxygenation B12 supports red blood cell production & blood flow , improving oxygen and nutrient delivery to damaged nerves